![Joanne Beck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joanne Beck
Direktor/Vorstandsmitglied bei
Orchard Therapeutics (Europe) Ltd.
Profil
Joanne T.
Beck is currently Director at Orchard Therapeutics (Europe) Ltd. since 2018.
Former roles include Chief Operating Officer & Director at Astria Therapeutics, Inc. from 2019 to 2026, Independent Non-Executive Director at Orchard Therapeutics Plc from 2018 to 2024, Director at Alliance for Regenerative Medicine in 2019, EVP-Pharmaceutical Development & Operations at Celgene Corp.
from 2016 to 2019, Chief Technology Officer at Abata Therapeutics, Inc. from 2024 to 2025, Chief Technology Officer at Aerium Therapeutics, Inc. from 2022 to 2024, Chief Operating Officer at Boston Pharmaceuticals, Inc. from 2019 to 2022, Senior Vice President-Pharmaceutical Development at Shire Ltd. from 2012 to 2016, and Head-Global Business Excellence at Abbott Vascular Instruments GmbH from 2004 to 2012.
Education includes undergraduate studies at Lewis & Clark College (Oregon) and a doctorate from Oregon Health & Science University.
Aktive Positionen von Joanne Beck
| Unternehmen | Position | Beginn |
|---|---|---|
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Direktor/Vorstandsmitglied | 09.07.2018 |
Ehemalige bekannte Positionen von Joanne Beck
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Geschäftsführer | 23.01.2026 |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2025 |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2024 |
| ORCHARD THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 24.01.2024 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Vorstandsvorsitzender | 10.05.2022 |
Ausbildung von Joanne Beck
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
47
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Lewis & Clark College (Oregon)
 Lewis & Clark College (Oregon) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oregon Health & Science University
 Oregon Health & Science University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Shire Ltd.
 Shire Ltd. Financial ConglomeratesFinance Operates as dormant company | Finance |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Abbott Vascular Instruments GmbH | |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Health Technology |
Aerium Therapeutics, Inc.
Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats | Commercial Services |
